Advanced Malignancies
Showing NaN - NaN of 11
Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)
Recruiting
- Advanced Malignancies
- +4 more
- Avelumab
- +7 more
-
Fayetteville, Arkansas
- +61 more
Jan 10, 2023
Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01876, Nivolumab, Ipilimumab)
Completed
- Advanced Malignancies
- Metastatic Cancer
- INCAGN01876
- +2 more
-
Los Angeles, California
- +37 more
Dec 6, 2022
All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,
Active, not recruiting
- All Malignancies
- +11 more
- Tazemetostat
- +2 more
-
Encinitas, California
- +9 more
May 20, 2022
NSCLC, Lung Cancer, Advanced Malignancies Trial in Worldwide (Brigatinib, Crizotinib)
Completed
- Non-small Cell Lung Cancer
- +3 more
-
Sedona, Arizona
- +90 more
Jul 27, 2021
Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in Spain, United Kingdom, United States (Azacitidine,
Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01949)
Completed
- Advanced Malignancies
- Metastatic Cancer
-
New Brunswick, New Jersey
- +7 more
May 6, 2020
Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,
Completed
- Advanced Cancer
- Advanced Malignancies
- Cemiplimab
- +7 more
-
Gilbert, Arizona
- +46 more
Jan 23, 2020
Advanced Malignancies Trial in Barcelona (MLN8054)
Terminated
- Advanced Malignancies
-
Barcelona, SpainCiutat Sanitaria Vall d'Hebron
Sep 20, 2013